Improving asthma symptom awareness in older adults
A Randomized Trial of Perception of Airflow Limitation Training to Improve Outcomes for Older Adults With Asthma
NA · Icahn School of Medicine at Mount Sinai · NCT06612294
This study is trying to help older adults with asthma better recognize their breathing problems so they can manage their condition more effectively.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | Icahn School of Medicine at Mount Sinai (other) |
| Locations | 2 sites (New York, New York and 1 other locations) |
| Trial ID | NCT06612294 on ClinicalTrials.gov |
What this trial studies
This study focuses on older adults with asthma, aiming to enhance their awareness of expiratory airflow limitation, which is crucial for better asthma management. The intervention involves training participants to perceive airway obstruction through feedback from peak expiratory flow (PEF) measurements, combined with motivational interviewing to encourage self-management behaviors. The research addresses the significant gap in asthma outcomes among older adults, particularly those from minoritized backgrounds, by targeting their perception of asthma symptoms.
Who should consider this trial
Good fit: Ideal candidates are individuals over 60 years old who have uncontrolled asthma and can communicate in English or Spanish.
Not a fit: Patients with dementia, COPD, congestive heart failure, or significant smoking history may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved asthma management and reduced hospitalization rates among older adults.
How similar studies have performed: Previous studies have indicated that enhancing symptom perception can improve asthma outcomes, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 60 years * English or Spanish speaking * Self-report or physician diagnosis of asthma \>1 year ago * Uncontrolled asthma Exclusion Criteria: * Dementia * Chronic obstructive pulmonary disease (COPD), or other chronic respiratory illnesses, * Congestive Heart Failure (CHF, New York Heart Association \[NYHA\] stages 4-5) * Cigarette smoking \>15 packs-years
Where this trial is running
New York, New York and 1 other locations
- Ichan School of Medicine at Mount Sinai — New York, New York, United States (RECRUITING)
- Albert Einstein College of Medicine — The Bronx, New York, United States (NOT_YET_RECRUITING)
Study contacts
- Principal investigator: Juan Wisnivesky, MD, DrPH — Division Chief, General Internal Medicine
- Study coordinator: Juan Wisnivesky, MD, DrPH
- Email: juan.wisnivesky@mountsinai.org
- Phone: 212-824-7845
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Asthma